Compugen LTD

Zurit Levine, SVP, Business Development of Compugen Ltd, reported multiple transactions in common stock on July 29, 2026.

David Silberman, Chief Financial Officer of Compugen Ltd, reported multiple transactions in common stock on July 29, 2026.

Eran Ophir, President and CEO and a Director of Compugen Ltd, received 200,000 shares of common stock on July 29, 2026.

Anat Cohen-Dayag, a Director of Compugen Ltd, received 100,000 shares of common stock on July 29, 2026.

Eran Perry, a Director of Compugen Ltd, reported multiple transactions in common stock on July 29, 2026.

Pierre Ferre, Chief Operating Officer of Compugen Ltd, received 70,000 shares of common stock on July 29, 2026.

Bristol-Myers Squibb Company has filed an amended Schedule 13G, reporting a 2.06% passive beneficial ownership stake in Compugen Ltd. as of December 31, 2024.